Context It is unclear whether a magnetic resonance imaging (MRI)-targeted transperineal
(TP) biopsy can improve the detection of clinically significant prostate cancer (csPCa) …

Background As recent prospective studies showed targeted biopsies (TBs) to be superior to
systematic biopsies (SBs), magnetic resonance imaging (MRI) is gaining wider acceptance …

Objectives: To compare the detection rates of overall prostate cancer (PCa) and clinically
significant PCa (csPCa) and the median percentage of cancer per biopsy core between MRI …

PSA has led to a drastic increase in the detection of prostate cancer, rendering this
biomarker the gateway for the diagnostic pathway of prostatic neoplasms. However, the …

Quality is currently recognized as the pre-requisite for delivering the clinical benefits
expected by magnetic resonance imaging (MRI)-informed prostate biopsy (MRI-i-PB) in …

Prostate cancer is the second most common malignancy in men worldwide. Systematic
transrectal prostate biopsy is commonly used to obtain tissue to establish the diagnosis. In …

Context The introduction of magnetic resonance imaging-guided biopsies (MRI-GB) has
changed the paradigm concerning prostate biopsies. Three techniques of MRI-GB are …

Transrectal ultrasound (TRUS)-guided systematic biopsy, the current gold standard for the
detection of prostate cancer, suffers from low sensitivity for clinically significant cancer. The …

Aim: To present a summary of the updated guidelines of the Italian Prostate Biopsies Group
following the best recent evidence of the literature. Materials and Methods: A systematic …

Context Magnetic resonance imaging (MRI)-targeted prostate biopsy (MRI-TB) may be an
alternative to systematic biopsy for diagnosing prostate cancer. Objective The primary aims …